24
Participants
Start Date
March 23, 2018
Primary Completion Date
May 29, 2023
Study Completion Date
January 26, 2026
Cetuximab
Loading dose on day 1 of week 1 of 400 mg/m2 via IV over 2 hours Subsequent doses of 250 mg/m2 via IV over 1 hour weekly for 4 weeks (28 days) in combination with palbociclib
Palbociclib
125 mg taken orally once daily on days 1-21, then 7 days off
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill